RecruitingPHASE1, PHASE2NCT05552755
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
Studying Familial adenomatous polyposis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Recursion Pharmaceuticals Inc.
- Intervention
- REC-4881(drug)
- Enrollment
- 67 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2026
Study locations (17)
- Mayo Clinic - Scottsdale, Scottsdale, Arizona, United States
- Del Sol Research Management, Tucson, Arizona, United States
- Medical Associates Research Group, San Diego, California, United States
- GI Pros, Naples, Florida, United States
- Digestive and Liver Center of Florida, Orlando, Florida, United States
- Gastroenterology Health Partners, PLLC, New Albany, Indiana, United States
- Tandem Clinical Research, Marrero, Louisiana, United States
- Corewell Health (Spectrum Health Hospitals Colorectal Cancer Multis), Grand Rapids, Michigan, United States
- Mayo Clinic - Rochester, Rochester, Minnesota, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- University of Pennsylvania, Philadelphia, Pennsylvania, United States
- Gastro One-8110 Walnut Rs, Cordova, Tennessee, United States
- Vanderbilt Digestive Center, Nashville, Tennessee, United States
- Genetic Cancer Prevention Clinic - UT Southwestern, Dallas, Texas, United States
- MD Anderson Cancer Center, Houston, Texas, United States
- +2 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05552755 on ClinicalTrials.govOther trials for Familial adenomatous polyposis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06641310Trial of Exercise Therapy in Familial Adenomatous Polyp (FAP)University of Michigan Rogel Cancer Center
- RECRUITINGPHASE1NCT05630794Testing for Safety and Colorectal Cancer Preventive Effects of ONC201National Cancer Institute (NCI)
- RECRUITINGPHASE3NCT06950385Phase 3 Trial of eRapa in Patients With Familial Adenomatous PolyposisRapamycin Holdings Inc.
- RECRUITINGNANCT06538402Ten Versus Fifteen Centimeter Pouch in IPAA SurgeryOdense University Hospital
- RECRUITINGNCT06614738Microbial and Environmental Factors Associated with Polyps Development in Familial Adenomatous Polyposis (MicrobEnvironment in FAP)Hospices Civils de Lyon
- RECRUITINGNANCT06578637Investigation of β-hydroxybutyrate Supplementation as Chemoprevention in Familial Adenomatous PolyposisAbramson Cancer Center at Penn Medicine
- RECRUITINGPHASE3NCT06545526Chemopreventive Effect of Combination of Celecoxib and Metformin in Patients With Familial Adenomatous PolyposisYonsei University
- ACTIVE NOT RECRUITINGNCT07461246Familial Adenomatous Poliposys Italian Network (Rete Italiana Poliposi Adenomatosa Familiare)Fondazione IRCCS Istituto Nazionale dei Tumori, Milano